Original Research
Published on 26 May 2023
Risk and promise: an 11-year, single-center retrospective study of severe acute GVHD in pediatric patients undergoing allogeneic HSCT for nonmalignant diseases
in Pediatric Hematology and Hematological Malignancies

- 1,788 views














